106 related articles for article (PubMed ID: 11054668)
21. Evidence for the ability of nucleophosmin/B23 to bind ATP.
Chang JH; Lin JY; Wu MH; Yung BY
Biochem J; 1998 Feb; 329 ( Pt 3)(Pt 3):539-44. PubMed ID: 9445380
[TBL] [Abstract][Full Text] [Related]
22. Combination of a potent 20-epi-vitamin D3 analogue (KH 1060) with 9-cis-retinoic acid irreversibly inhibits clonal growth, decreases bcl-2 expression, and induces apoptosis in HL-60 leukemic cells.
Elstner E; Linker-Israeli M; Umiel T; Le J; Grillier I; Said J; Shintaku IP; Krajewski S; Reed JC; Binderup L; Koeffler HP
Cancer Res; 1996 Aug; 56(15):3570-6. PubMed ID: 8758928
[TBL] [Abstract][Full Text] [Related]
23. Down-regulation of nucleophosmin/B23 mRNA delays the entry of cells into mitosis.
Jiang PS; Yung BY
Biochem Biophys Res Commun; 1999 Apr; 257(3):865-70. PubMed ID: 10208875
[TBL] [Abstract][Full Text] [Related]
24. Characterization and cellular localization of nucleophosmin/B23 in HeLa cells treated with selected cytotoxic agents (studies of B23-translocation mechanism).
Chan PK
Exp Cell Res; 1992 Nov; 203(1):174-81. PubMed ID: 1426041
[TBL] [Abstract][Full Text] [Related]
25. Involvement of nPKC-MAPK pathway in the decrease of nucleophosmin/B23 during megakaryocytic differentiation of human myelogenous leukemia K562 cells.
Chou CC; Yung BY; Hsu CY
Life Sci; 2007 May; 80(22):2051-9. PubMed ID: 17448503
[TBL] [Abstract][Full Text] [Related]
26. Retinoic acid is able to induce interferon regulatory factor 1 in squamous carcinoma cells via a STAT-1 independent signalling pathway.
Percario ZA; Giandomenico V; Fiorucci G; Chiantore MV; Vannucchi S; Hiscott J; Affabris E; Romeo G
Cell Growth Differ; 1999 Apr; 10(4):263-70. PubMed ID: 10319996
[TBL] [Abstract][Full Text] [Related]
27. Retinoic acid resistance in NB4 APL cells is associated with lack of interferon alpha synthesis Stat1 and p48 induction.
Pelicano L; Brumpt C; Pitha PM; Chelbi-Alix MK
Oncogene; 1999 Jul; 18(27):3944-53. PubMed ID: 10435617
[TBL] [Abstract][Full Text] [Related]
28. Differential effects of retinoic acid (RA) and N-(4-hydroxyphenyl) retinamide (4-HPR) on cell growth, induction of differentiation, and changes in p34cdc2, Bcl-2, and actin expression in the human promyelocytic HL-60 leukemic cells.
Dipietrantonio A; Hsieh TC; Wu JM
Biochem Biophys Res Commun; 1996 Jul; 224(3):837-42. PubMed ID: 8713132
[TBL] [Abstract][Full Text] [Related]
29. Ras-dependent recruitment of c-Myc for transcriptional activation of nucleophosmin/B23 in highly malignant U1 bladder cancer cells.
Yeh CW; Huang SS; Lee RP; Yung BY
Mol Pharmacol; 2006 Oct; 70(4):1443-53. PubMed ID: 16857742
[TBL] [Abstract][Full Text] [Related]
30. Synergistic effects of clinically achievable concentrations of 12-O-tetradecanoylphorbol-13-acetate in combination with all-trans retinoic acid, 1alpha,25-dihydroxyvitamin D3, and sodium butyrate on differentiation in HL-60 cells.
Zheng X; Chang RL; Cui XX; Kelly KA; Shih WJ; Lin Y; Strair R; Suh J; Han ZT; Rabson A; Conney AH
Oncol Res; 2000; 12(9-10):419-27. PubMed ID: 11697820
[TBL] [Abstract][Full Text] [Related]
31. In vivo interaction of nucleophosmin/B23 and protein C23 during cell cycle progression in HeLa cells.
Liu HT; Yung BY
Cancer Lett; 1999 Sep; 144(1):45-54. PubMed ID: 10503877
[TBL] [Abstract][Full Text] [Related]
32. Nucleophosmin/B23 regulates transcriptional activation of E2F1 via modulating the promoter binding of NF-kappaB, E2F1 and pRB.
Lin CY; Liang YC; Yung BY
Cell Signal; 2006 Nov; 18(11):2041-8. PubMed ID: 16725311
[TBL] [Abstract][Full Text] [Related]
33. Association of nucleophosmin/B23 mRNA expression with clinical outcome in patients with bladder carcinoma.
Tsui KH; Cheng AJ; Chang Pe; Pan TL; Yung BY
Urology; 2004 Oct; 64(4):839-44. PubMed ID: 15491744
[TBL] [Abstract][Full Text] [Related]
34. Nucleophosmin/B23, a multifunctional protein that can regulate apoptosis.
Ye K
Cancer Biol Ther; 2005 Sep; 4(9):918-23. PubMed ID: 16103750
[TBL] [Abstract][Full Text] [Related]
35. Nucleolar localization of nucleophosmin/B23 requires GTP.
Finch RA; Revankar GR; Chan PK
J Biol Chem; 1993 Mar; 268(8):5823-7. PubMed ID: 8095498
[TBL] [Abstract][Full Text] [Related]
36. Oncogenic role of nucleophosmin/B23.
Yung BY
Chang Gung Med J; 2007; 30(4):285-93. PubMed ID: 17939258
[TBL] [Abstract][Full Text] [Related]
37. Synergistic effect of retinoic acid and calcium ionophore A23187 on differentiation, c-myc expression, and membrane tyrosine kinase activity in human promyelocytic leukemia cell line HL-60.
Chapekar MS; Hartman KD; Knode MC; Glazer RI
Mol Pharmacol; 1987 Feb; 31(2):140-5. PubMed ID: 3100942
[TBL] [Abstract][Full Text] [Related]
38. Synergistic effects of curcumin on all-trans retinoic acid- and 1 alpha,25-dihydroxyvitamin D3-induced differentiation in human promyelocytic leukemia HL-60 cells.
Liu Y; Chang RL; Cui XX; Newmark HL; Conney AH
Oncol Res; 1997; 9(1):19-29. PubMed ID: 9112257
[TBL] [Abstract][Full Text] [Related]
39. Retinoic acid and IFN inhibition of cell proliferation is associated with apoptosis in squamous carcinoma cell lines: role of IRF-1 and TGase II-dependent pathways.
Giandomenico V; Lancillotti F; Fiorucci G; Percario ZA; Rivabene R; Malorni W; Affabris E; Romeo G
Cell Growth Differ; 1997 Jan; 8(1):91-100. PubMed ID: 8993838
[TBL] [Abstract][Full Text] [Related]
40. [Chronological characteristics of retinoic acid-induced HL-60 cell differentiation].
Li L; Liu HY; Han R
Zhonghua Zhong Liu Za Zhi; 1994 Jul; 16(4):255-8. PubMed ID: 7805552
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
